[Comment] Sustained unresponsiveness in peanut oral immunotherapy

20:46 EDT 12 Sep 2019 | The Lancet

Peanut allergy is a potentially life-threatening disease with substantial impact on the quality of life of patients and carers.1 Many initiatives are underway to develop treatment alternatives for strict peanut avoidance. Subcutaneous immunotherapy with aqueous peanut extract was found to be too dangerous.2 Alternatives such as sublingual, epicutaneous, and oral immunotherapies are being tested. So far, oral immunotherapy (OIT) has proved most effective in achieving meaningful desensitisation while on therapy.

Original Article: [Comment] Sustained unresponsiveness in peanut oral immunotherapy


More From BioPortfolio on "[Comment] Sustained unresponsiveness in peanut oral immunotherapy"

Quick Search

Relevant Topics

The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...